We are an Innovative Therapeutic Apheresis company focused on cleansing patient blood of neutrophil extracellular traps (NETs) looking to revolutionize how we can control  the human immune and inflammatory response to disease.

Neutrophil Extracellular Traps

Neutrophil Extracellular Traps (NETs) are fibers of  decondensed  DNA decorated with cytotoxic proteins that have been released from activated neutrophils. NETs have been recognized as one of the major driving factors in the development of sepsis, COVID-19, cancer, acute organ failure, autoimmune flares, and neurodegeneration including Alzheimer’s disease.

NucleoCapture Device

Santersus AG has developed a NucleoCapture selective apheresis device – first in class fully functional product designed to capture and remove circulating NETs from patient blood.